Printer Friendly
The Free Library
19,607,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA approves use of pre-clinical research data on OrthoLogic 1000 bone growth stimulator.


PHOENIX--(BUSINESS WIRE)--May 13, 1997--OrthoLogic Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:OLGC OLGC Ontario Lottery and Gaming Corporation ) Tuesday said that the Food and Drug Administration has approved the use of pre-clinical research data in the marketing of the OrthoLogic 1000 bone growth stimulator.

A year ago OrthoLogic discontinued dis·con·tin·ue  
v. dis·con·tin·ued, dis·con·tin·u·ing, dis·con·tin·ues

v.tr.
1. To stop doing or providing (something); end or abandon:
 using some research data on the OrthoLogic 1000 in response to an FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 warning letter.

OrthoLogic then compiled its pre-clinical data from laboratory cell studies in the form of a promotional brochure and submitted it to the FDA for review. The brochure, titled "Biophysical Stimulation of Fracture-Healing Mediated me·di·ate  
v. me·di·at·ed, me·di·at·ing, me·di·ates

v.tr.
1. To resolve or settle (differences) by working with all the conflicting parties:
 by IGF-II," received what is called a pre-market approval supplement from the FDA. This means that the research data can again be used by the company in marketing the OrthoLogic 1000 to orthopaedic surgeons.

"OrthoLogic is committed to basic research and obtaining additional scientific understanding of how our products work. We are involved in numerous research programs, both in our labs in Phoenix and in distinguished academic institutions. We are very pleased to be able to utilize this basic scientific research in the promotion of the OrthoLogic 1000. Although human clinical results cannot be extrapolated directly from animal and cell studies, it is important that surgeons be exposed to these data so that they can stay abreast of current thinking as to the mechanism of action of the OrthoLogic 1000," said Frank P. Magee, D.V.M., OrthoLogic's executive vice president for research and development.

OrthoLogic develops, manufactures and markets proprietary technologically advanced orthopaedic devices designed to promote the healing Healing
See also Medicine.

Achilles’ spear

had power to heal whatever wound it made. [Gk. Lit.: Iliad]

Agamede

Augeas’ daughter; noted for skill in using herbs for healing. [Gk. Myth.
 of musculoskeletal musculoskeletal /mus·cu·lo·skel·e·tal/ (-skel´e-t'l) pertaining to or comprising the skeleton and muscles.

mus·cu·lo·skel·e·tal
adj.
Relating to or involving the muscles and the skeleton.
 tissue. Founded in 1987, the company has headquarters in Phoenix.

CONTACT: OrthoLogic Corp., Phoenix

Allan Weinstein, 602/437-5520

or

The Financial Relations Board

Daniel Saks or David Lawton (general information),

Moira Conlon (analyst information),

310/442-0599

Darcy Bretz (media contact), 312/266-7800
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 13, 1997
Words:292
Previous Article:U.S. Global Gold Fund wins with Bre-X.
Next Article:Eldorado Gold - year end reserve/resource.
Topics:



Related Articles
Director of Regulatory Affairs Joins OrthoLogic.
OrthoLogic expands clinical trails for delayed union fractures; Interim analysis of delayed union clinical trial has positive results, OrthoLogic...
Patient registry data reported for the OrthoLogic 1000; Patient registry data shows 78% overall heal rate in an average of 4.1 months.
OrthoLogic reports record sales for third quarter 1995.
OrthoLogic reports first quarterly profit and record sales; First ever profitable quarter; Sales jump 196 percent year to year.
Orthologic resolves FDA warning letter issues.
Rebuilding strong bones.
Medicinal EMFs.
Seattle Genetics Adds Two Oncology Veterans to Scientific Advisory Board.
Pluristem Expects to Submit Pre-IND Document to FDA by End of 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles